Ledger.Open graph →
SEC Form D · filed September 2, 2022

Rose Therapeutics, Inc

Offering
$1.0M
Sold
$650K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NORRISTOWN, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Matthew Wotiz · Norristown, PAExec · DirectorTimothy Langloss · Tustin, CAExec · DirectorIra Sanders · Weston, FLDirectorMatthew Wotiz · Norristown, PAExec · DirectorTimothy Langloss · New York, NYExec · DirectorIra Sanders · Weston, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗